dr. bond on second cancers following cll treatment
Published 5 years ago • 361 plays • Length 1:41Download video MP4
Download video MP3
Similar videos
-
0:55
factors identified for risk of second cancer in cll following btk treatment
-
0:58
what is cll, and does everyone really needs treatment? | dr. jeff sharman | oncology brothers #2023
-
1:58
dr. shadman on fixed durations of treatment in cll
-
0:49
front-line treatment options for cll | dr. jeff sharman | oncology brothers #2023
-
1:54
dr. fakhri on selecting the optimal treatment in cll
-
1:24
dr. jennifer brown on ibrutinib, idelalisib, and other agents for cll
-
1:18
dr. ferrajoli on individualized treatment of cll
-
32:50
dr vighnesh bharath - cll – treatment options; new drugs; coverage
-
0:56
dr. al-sawaf on continual mrd assessment after venetoclax/obinutuzumab in cll
-
2:11
dr. ferrajoli on treatment of elderly patients with cll
-
0:56
differential when thinking about cll | dr. jeff sharman | oncology brothers #2023
-
1:39
dr. wierda on role of rituximab biosimilar in evolving cll treatment paradigm
-
4:07
management of cll progression after ibrutinib
-
2:20
dr. awan on the role of chemotherapy in cll
-
9:58
dr. graeme fraser - cll patient prognosis
-
1:16
dr. woyach on ibrutinib and peripheral lymphocytosis in patients with chronic lymphocytic leukemia
-
1:57
dr. wierda on chemoimmunotherapy in cll
-
1:51
dr. smith on frontline treatment considerations in cll
-
1:40
dr. leslie on real-world outcomes of patients with cll treated with acalabrutinib